‘Love Hormone’ Promises Safer Births After Pfizer Flop

A hormone treatment based on technology used in Pfizer Inc.’s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.